In this review, aspects of the synthesis, framework topologies, and biomedical applications of highly porous metal–organic frameworks are discussed. The term “highly porous metal–organic frameworks” (HPMOFs) is used to denote MOFs with a surface area larger than 4000 m2 g−1. Such compounds are suitable for the encapsulation of a variety of large guest molecules, ranging from organic dyes to drugs and proteins, and hence they can address major contemporary challenges in the environmental and biomedical field. Numerous synthetic approaches towards HPMOFs have been developed and discussed herein. Attempts are made to categorise the most successful synthetic strategies; however, these are often not independent from each other, and a combination of different parameters is required to be thoroughly considered for the synthesis of stable HPMOFs. The majority of the HPMOFs in this review are of special interest not only because of their high porosity and fascinating structures, but also due to their capability to encapsulate and deliver drugs, proteins, enzymes, genes, or cells; hence, they are excellent candidates in biomedical applications that involve drug delivery, enzyme immobilisation, gene targeting, etc. The encapsulation strategies are described, and the MOFs are categorised according to the type of biomolecule they are able to encapsulate. The research field of HPMOFs has witnessed tremendous development recently. Their intriguing features and potential applications attract researchers’ interest and promise an auspicious future for this class of highly porous materials.
20 January 2022 in Journal of Materials Chemistry B
Metal–organic frameworks (MOFs) are promising multifunctional porous materials for biomedical and environmental applications. Here, we report synthesis and characterization of a new MOF based on the tetrahedral secondary building unit [Zn4O(CBAB)3]n (NUIG4), where CBABH2 = 4-((4-carboxybenzylidene)amino)benzoic acid. NUIG4 belongs to the family of MOFs with primitive cubic pcu topology, being a rare example with 4-fold interpenetration. The pore architecture enables unprecedentedly high doxorubicin (DOX) loading capacity (1955 mg DOX/g NUIG4) with pH-controlled release. Solid-state NMR and ab initio modeling confirmed formation of aromatic π–π stacking interactions between DOX and the framework. Preliminary cell-line experiments suggested a protective effect of NUIG4 on healthy HDF cells against DOX toxicity. NUIG4 also displays potential for adsorptive small-molecule gas separation, with a BET surface area of 1358 m2 g−1 and high selectivity of 2.75 for C2H2 over CO2.
OnG6 MOFs are mesoporous MOFs derived from the pro-drug ligand 4,4′-azodisalicylic acid. They can encapsulate antibiotics such as isoniazid and ciprofloxacin. The ciprofloxacin-loaded OnG6 exhibit antimicrobial activity against S. aureus and E. coli .
17 December 2024 in Angewandte Chemie International Edition
Polycrystalline [FeL2][BF4]2 (L=2,6‐di(pyrazol‐1‐yl)isonicotinonitrile) exhibits an abrupt hysteretic spin transition near 240 K, with a shoulder on the warming branch whose appearance depends on the sample history. The freshly isolated material is a ca 60 : 40 mixture of triclinic (HS1) and tetragonal (HS2) high‐spin polymorphs, which are structurally closely related. Both HS1 and HS2 undergo a high→low‐spin transition on cooling at 230±10 K. HS1 transforms to a new triclinic low‐spin phase with a doubled unit cell volume (LS3), while HS2 forms a monoclinic low‐spin phase (LS4) with similar unit cell dimensions to HS2. Single crystals of LS3 and LS4 both convert to HS1 on rewarming. The low→high‐spin transition for LS4 is ca 10 K higher in temperature than for LS3, explaining the asymmetric thermal hysteresis. Powder diffraction, calorimetry and magnetic data show that multiple cycling about the spin‐transition leads to slow enrichment of the HS1 and LS3 phases at the expense of HS2 and LS4. That is consistent with the HS2/LS4 fraction of the polycrystalline sample undergoing rare, bifurcated HS2→(LS3+LS4) and LS4→(HS1+HS2) phase transitions. The rate of enrichment of HS1/LS3 differed between these experiments, implying it is sample and/or measurement‐dependent. Three other salts of this iron(II) complex and the coordination polymer [Ag(μ‐L)]BF4 are also briefly described.
The development of drug carriers with efficient absorption and controlled delivery properties is crucial for advancing medical treatments. Metal–organic frameworks (MOFs) with tunable porosity and a large surface area represent a promising class of materials for this application. Among them, NUIG4 stands out as a biocompatible MOF that exhibits exceptionally high doxorubicin (Dox) absorption (1995 mg dox/g NUIG4) and pH-controlled release properties. In this study, we report the synthesis and characterisation of multivariate MOFs (MV-NUIG4), which are analogues of NUIG4 that maintain the same topology while incorporating different functional groups within their framework. Eight new MV-NUIG4 MOFs have been synthesised through in situ reactions of the corresponding 4-aminobenzoic acid derivative with 4-formylbenzoic acid. The compounds were thoroughly characterised using a range of techniques, including powder X-ray diffraction, infrared spectroscopy, 1H-NMR, and single-crystal X-ray crystallography. The experimental ratio of the reagents and ligand precursors for the synthesis of MV-NUIG4 MOFs matched the ratio of the linkers in the final products. These structures incorporate additional functional groups, such as methyl and hydroxyl, in varying ratios. Computational modelling was used to provide further insight into the crystal structure of the MOFs, revealing a random distribution of the functional groups in the framework. The Dox absorption and release capacity of all analogues were studied, and the results revealed that all analogues displayed high drug absorption in the range of 1234–1995 mg Dox/g MOF. Furthermore, the absorption and release rates of the drug are modulated by the ratio of functional groups, providing a promising approach for controlling drug delivery properties in MOFs.
Polycrystalline [FeL2][BF4]2 (L=2,6‐di(pyrazol‐1‐yl)isonicotinonitrile) exhibits an abrupt hysteretic spin transition near 240 K, with a shoulder on the warming branch whose appearance depends on the sample history. The freshly isolated material is a ca 60 : 40 mixture of triclinic (HS1) and tetragonal (HS2) high‐spin polymorphs, which are structurally closely related. Both HS1 and HS2 undergo a high→low‐spin transition on cooling at 230±10 K. HS1 transforms to a new triclinic low‐spin phase with a doubled unit cell volume (LS3), while HS2 forms a monoclinic low‐spin phase (LS4) with similar unit cell dimensions to HS2. Single crystals of LS3 and LS4 both convert to HS1 on rewarming. The low→high‐spin transition for LS4 is ca 10 K higher in temperature than for LS3, explaining the asymmetric thermal hysteresis. Powder diffraction, calorimetry and magnetic data show that multiple cycling about the spin‐transition leads to slow enrichment of the HS1 and LS3 phases at the expense of HS2 and LS4. That is consistent with the HS2/LS4 fraction of the polycrystalline sample undergoing rare, bifurcated HS2→(LS3+LS4) and LS4→(HS1+HS2) phase transitions. The rate of enrichment of HS1/LS3 differed between these experiments, implying it is sample and/or measurement‐dependent. Three other salts of this iron(II) complex and the coordination polymer [Ag(μ‐L)]BF4 are also briefly described.